Back to results
US 2011/0256558 A1Published application
Measuring levels of fibrocystin-l
AssigneeMayo Foundation for Medical Education and Research
InventorsPeter C. Harris, Marie C. Hogan, Christopher J. Ward, Matthew D. Griffin
Life of this patent
Estimating the term…
Abstract
Nucleic acids encoding fibrocystin-L polypeptides and fibrocystin-L polypeptides are provided. Antibodies against the polypeptides, vectors and host cells containing the nucleic acids, methods for using the nucleic acids and polypeptides, and compositions and articles of manufacture also are provided.
Claims8
A method for determining whether a subject has endometrial cancer, comprising:
- (a) using the antibody of claim 1 to measure the level of fibrocystin-L polypeptide in a biological sample from the subject, and
- (b) determining that the subject has endometrial cancer if the level of fibrocystin-L polypeptide in the biological sample is increased relative to the level in a corresponding control sample, or determining that the subject does not have endometrial cancer if the level of fibrocystin-L polypeptide in the biological sample is not increased relative to the level in the corresponding control sample.
Dependencies are inferred from the claim text.